Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose glucocorticosteroids for idiopathic sudden sensorineural hearing loss
DRKS00010738Phase 3Terminated
- Sponsor
- Martin Luther University Halle-Wittenberg
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of prednisolone and dexamethasone in idiopathic sudden sensorineural hearing loss (ISSNHL) (3 arms), sponsored by Martin Luther University Halle-Wittenberg. Started Jul 2016; status: terminated.
02
Drugs
prednisolonedexamethasone
03
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)
Beyond the preview
Go deeper on DRKS00010738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00010738.